- 询价
- 各种规格
- 2025年12月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
| 序号 | 产品名称 | 订货号 |
| Chondroitin disaccharide Δdi-0S, sodium salt Formula: C14H20NNaO11 Molecular Weight: 401.3 |
C3201-5MG | |
| C3201-10MG | ||
| Chondroitin disaccharide Δdi-4S, sodium salt Formula: C14H19NNa2O14S Molecular Weight: 503.34 |
C3202-5MG | |
| C3202-10MG | ||
| Chondroitin disaccharide Δdi-6S, sodium salt Formula: C14H19NNa2O14S Molecular Weight: 503.34 |
C3203-5MG | |
| C3203-10MG | ||
| C3203-25MG | ||
| Chondroitin disaccharide ΔDi-diSE, sodium salt Formula: C14H18NNa3O17S2 Molecular Weight: 605.39 |
C3204-1MG | |
| C3204-5MG | ||
| Chondroitin disaccharide ΔDi-diSB, sodium salt Formula: C14H18NNa3O17S2 Molecular Weight: 605.39 |
C3205-1MG | |
| C3205-5MG | ||
| Chondroitin disaccharide ΔDi-diSD, sodium salt Formula: C14H18NNa3O17S2 Molecular Weight: 605.39 |
C3206-1MG | |
| C3206-5MG | ||
| Chondroitin disaccharide ΔDi-triS, sodium salt Formula: C14H17NNa4O20S3 Molecular Weight: 707.43 |
C3207-1MG | |
| C3207-5MG | ||
| Chondroitin disaccharide ΔDi-UA2S, sodium salt Formula: C14H19NNa2O14S Molecular Weight: 503.34 |
C3208-1MG | |
| C3208-5MG | ||
| Hyaluronic acid disaccharide ΔDiHA, sodium salt Formula: C14H20NNaO11 Molecular Weight: 401.3 CAS No: 149368-06-9 |
C3209-2MG | |
| C3209-5MG | ||
| Chondroitin disaccharide Δdi-4S, sodium salt Formula: C14H21NNa2O15S Molecular Weight: 521.36 CAS No: 149368-52-0 |
C4202-1MG | |
| C4202-2MG | ||
| Chondroitin disaccharide Δdi-6S, sodium salt Formula: C14H21NNa2O15S Molecular Weight: 521.36 CAS No: 149458-08-2 |
C4203-1MG | |
| C4203-2MG | ||
| Heparin disaccharide I-S, sodium salt Formula: C12H15NNa4O19S3 Molecular Weight: 665.4 CAS No: 136098-10-7 |
H1001-1MG | |
| H1001-5MG | ||
| H1001-25MG | ||
| Heparin disaccharide II-S, sodium salt Formula: C12H16NNa3O16S2 Molecular Weight: 563.35 CAS No: 136098-05-0 |
H1002-500UG | |
| H1002-2MG | ||
| Heparin disaccharide III-S, sodium salt Formula: C12H16NNa3O16S2 Molecular Weight: 563.35 CAS No: 136098-03-8 |
H1003-1MG | |
| H1003-5MG | ||
| Heparin disaccharide IV-S, sodium salt Formula: C12H17NNa2O13S Molecular Weight: 461.31 CAS No: 136098-08-3 |
H1004-1MG | |
| H1004-2MG | ||
| Heparin disaccharide I-A, sodium salt Formula: C14H18NNa3O17S2 Molecular Weight: 605.39 CAS No: 136098-00-5 |
H1005-1MG | |
| H1005-2MG | ||
| H1005-5MG | ||
| Heparin disaccharide II-A, sodium salt Formula: C14H19NNa2O14S Molecular Weight: 503.34 CAS No: 136098-06-1 |
H1006-1MG | |
| H1006-5MG | ||
| Heparin disaccharide III-A, sodium salt Catalogue No: H1007 Formula: C14H19NNa2O14S Molecular Weight: 503.34 CAS No: 136098-11-8 |
H1007-1MG | |
| H1007-5MG | ||
| Heparin disaccharide IV-A, sodium salt Formula: C14H20NNaO11 Molecular Weight: 401.3 CAS No: 136098-07-2 |
H1008-500UG | |
| H1008-1MG | ||
| Heparin unsaturated disaccharide I-H, sodium salt Formula: C12H17NNa2O16S2 Molecular Weight: 541.37 CAS No: 136098-04-9 |
H1009-1MG | |
| H1009-2MG | ||
| Heparin unsaturated disaccharide II-H, sodium salt Formula: C12H18NNaO13S Molecular Weight: 439.32 CAS No: 136098-02-7 |
H1010-1MG | |
| H1010-2MG | ||
| Heparin unsaturated disaccharide III-H, sodium salt Formula: C12H18NNaO13S Molecular Weight: 439.32 CAS No: 136098-01-6 |
H1011-1MG | |
| H1011-2MG | ||
| Heparin unsaturated disaccharide IV-H Formula: C12H19NO10 Molecular Weight: 337.28 CAS No: 123228-39-7 |
H1012-1MG | |
| H1012-2MG | ||
| Heparin unsaturated disaccharide I-P, sodium salt Formula: C15H20NNa3O17S2 Molecular Weight: 619.42 CAS No: 149368-05-8 |
H1013-1MG | |
| H1013-2MG | ||
| De-N-sulfated heparin (Heparin I-H) sodium salt CAS No: 61932-66-9 |
H3001-50MG | |
| H3001-100MG | ||
| N-Acetyl-heparin (Heparin I-A) sodium salt CAS No: 134498-62-7 |
H3002-50MG | |
| H3002-100MG | ||
| N-Acetyl-de-O-sulfated heparin (Heparin IV-A) sodium salt CAS No: 133686-69-8 |
H3004-50MG | |
| H3004-100MG | ||
| Chondroitin sulfate CAS No: 9007-28-7 |
PS109-1G | |
| PS109-5G | ||
| PS109-20G | ||
| Heparin CAS No: 9005-49-6 |
PS115-1G | |
| PS115-250MG | ||
| Hyaluronic acid CAS No: 9004-61-9 |
PS116-50MG | |
| PS116-100MG |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验Characterization of Glycosaminoglycans by Capillary Electrophoresis
Glycosaminoglycans are linear, sulfated polysaccharides that are found in virtually all animal tissues. With the exception of hyaluronic acid, glycosaminoglycans are biosynthesized as proteoglycans
Isolation and Characterization of Glycosaminoglycans from Human Atheromatous Vessels
of the ECM involved in atherogenesis, the glycosaminoglycan(GAGs) have been reported to contribute to key events leading to the formation of atherosclerotic lesions (2 ). GAGs are linear acidic polysaccharides of variable length and composition, which occur
Preparation of Oligosaccharides from Sulfated Glycosaminoglycans Using Bacterial Enzymes
Although the polysaccharide backbone Glycosaminoglycans (GAGs) have been demonstrated to interact with a variety of proteins and such interactions are thought to be involved in the regulation of the physiological functions
技术资料暂无技术资料 索取技术资料
